Chicago / Edinburgh
LATEST FROM IPOX®

News

News and updates from IPOX®, including media mentions, interviews, research and press releases.

The Case for Indexing Chinese IPOs

We apply an event study methodology to the performance of China domiciled companies going public in Hong Kong and abroad between 1995 and 2008 and study the case for indexing the Chinese IPO sector with IPOX®, an innovative IPO indexing solution. For a sample of 373 Chinese IPOs, we find substantial initial returns. IPO performance is sensitive to the market condition at the time of going public and IPO issuing characteristics. IPO underperformance appears to be a short to medium term phenomenon and linked to the initial IPO characteristics such as the market condition at the time of going public, initial return, size and listing exchange. In the long-run, we do not find that Chinese IPOs underperform. This is driven by the return of few companies which describes the essence of the IPO market. We underline the case for indexing the performance of this dynamic sector by using IPOX®, which has been able to competitively capture the performance of IPOs within a semi-passive and scalable index approach. This study comes at an important juncture in Asian Equity Capital Markets Activity at a time when applications for listings of Chinese domiciled companies in Hong Kong are at an all-time high, promising a potentially large number of new entrants into the IPO sector, generally perceived to be a true proxy for China-linked growth and innovation.

IPOs: Insights from Seven European Countries

We perform a comparative country-by-country study of companies going public in the six largest Continental European markets and Sweden during 1988 and 1998, a time period characterized by IPO activity in a broad set of industries. By applying a common research methodology, we find broad similarity in the overall and cross-sectional initial pricing and long-run performance patterns. Positive long-run IPO performance is a function of a countriesí ability to attract ìNew Economyî IPOs. This helps to shed some light on the rational behind the frantic efforts made be individual European Stock Exchanges to establish ìNew Marketî segments during the late 1990s.

CME Group Announces Launch of E-mini IPOX® 100 U.S. Index Futures

CME Group , the world’s leading and most diverse derivatives marketplace, today announced the launch of E-mini IPOX® 100 U.S. Index Futures. The futures contract will be available for trading on the CME Globex electronic trading platform effective March 7, 2016, pending all relevant regulatory review periods. This contract will be listed with and subject to the rules and regulations of Chicago Mercantile Exchange. The new contract is designed to allow traders to capture the return dynamics of U.S. initial public offerings (IPOs) and corporate spin-offs, thereby providing the opportunity to trade on growth and innovation in the U.S. IPO market.

Do IPO index portfolios improve the investment opportunities for mean–variance investors?

We set out in this study to examine whether investors can improve their investment opportunity sets through the addition of an IPO index portfolio into various sets of benchmark portfolios. Using the IPOX® indices from the years 1980–2006, we find that adding an IPO index portfolio does lead to a statistically significant enlargement of the investment opportunity set for investors.

THE IPOX® NEWSLETTERS

Stay ahead of the next listing.

Research and insight from the global new listings market.

Explore our newsletters